Pharma tells the Federal Government: Transparency Works Both Ways

“File this under ‘how ironic.’
Drug makers are asking for more transparency from the government agency that is requiring them to be more transparent about how much they pay doctors.
The Pharmaceutical Research and Manufacturers of America, or PhRMA, is calling on the Centers for Medicare and Medicaid Services to further explain why the agency has removed one-third of the payment information from an online database that is due to be made public by Sept. 30.
Earlier this month, CMS said it would withhold about one-third of the payment data from the so-called “Open Payments” system. The agency also said it would return the records to drug makers because they were “intermingled,” including the erroneous linking of payment information for some doctors to still other doctors with similar names. CMS cited incorrect state medical-license numbers as one reason for the mix-up, among others.
CMS had collected partial-year 2013 payment data from the companies and began allowing doctors to go online for a preview this summer, before the database goes public by Sept. 30, in order to dispute any inaccuracies. But CMS closed the preview function for about 11 days to investigate the data intermingling and re-opened the site nearly two weeks ago. The missing one-third will be put back in the database at a later date, likely next year.”